G protein-coupled receptors as therapeutic target
Rocío Alcántara-Hernández1, David A Hernández-Espinosa1, Luz Del C Medina2
1Department of Cell Biology and Development, Institute of Cell Physiology, Universidad Nacional Autónoma de México.
Gaceta Medica De Mexico
|June 28, 2022
Summary
G protein-coupled receptors (GPCRs) are crucial drug targets. Understanding their atomic structure via X-ray crystallography and molecular modeling aids in developing more specific therapeutics.
Area of Science:
- Biochemistry
- Pharmacology
- Structural Biology
Background:
- Receptors, proteins encoded by DNA, offer insights into atomic structure and function upon crystallization.
- G protein-coupled receptors (GPCRs) are a diverse and abundant family, mediating endogenous ligand actions and implicated in various diseases.
- GPCRs are targeted by 30-40% of clinical medications and illicit drugs, highlighting their therapeutic significance.
Purpose of the Study:
- To review the structural and functional aspects of G protein-coupled receptors.
- To highlight the role of X-ray crystallography and molecular modeling in understanding GPCR-ligand interactions.
- To discuss the impact of structural insights on drug design and pharmacodynamic concepts.
Main Methods:
- X-ray crystallography to determine high-resolution GPCR structures.
- Molecular modeling (docking) to simulate and analyze receptor-ligand binding.
- Review of existing literature on GPCR structure, function, and pharmacology.
Main Results:
- X-ray crystallography reveals atomic-level details of GPCRs, including ligand-binding sites.
- Molecular modeling facilitates the identification of binding pockets for endogenous ligands and synthetic modulators.
- Structural data enables the design of more specific drugs targeting GPCRs.
Conclusions:
- Structural biology techniques like X-ray crystallography are essential for elucidating GPCR mechanisms.
- Computational tools like molecular modeling accelerate the development of novel therapeutics.
- Advances in GPCR structural understanding are transforming pharmacodynamic principles and drug discovery.
Related Concept Videos
01:15G Protein-coupled Receptors
13.1K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
13.1K
01:21G-protein Coupled Receptors
121.1K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
121.1K
01:30Transducer Mechanism: G Protein–Coupled Receptors
2.4K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
2.4K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K
01:09GPCRs Regulate Adenylyl Cylase Activity
5.9K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.9K
01:12GPCR Desensitization
6.4K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.4K